2023
DOI: 10.1021/acschemneuro.2c00771
|View full text |Cite
|
Sign up to set email alerts
|

Vanillin Benzothiazole Derivative Reduces Cellular Reactive Oxygen Species and Detects Amyloid Fibrillar Aggregates in Alzheimer’s Disease Brain

Abstract: The misfolding of amyloid beta (Aβ) peptides into Aβ fibrillary aggregates is a major hallmark of Alzheimer's disease (AD), which responsible for the excess production of hydrogen peroxide (H 2 O 2 ), a prominent reactive oxygen species (ROS) from the molecular oxygen (O 2 ) by the reduction of the Aβ-Cu(I) complex. The excessive production of H 2 O 2 causes oxidative stress and inflammation in the AD brain. Here, we have designed and developed a dual functionalized molecule VBD by using π-conjugation (C�C) in… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
8

Relationship

3
5

Authors

Journals

citations
Cited by 9 publications
(5 citation statements)
references
References 80 publications
0
2
0
Order By: Relevance
“…Copper( ii ) with and without Aβ may both be reduced to copper( i ) in the cellular environment that contains reducing agents (such as ascorbate and glutathione), as illustrated in copper( i )-Aβ may interact with O 2 to create ROS, such as O 2− , H 2 O 2 , and OH, which can oxidatively modify Aβ and alter its aggregation. 141–143 The copper binding sites and binding modes of monomeric Aβ peptides are flexible, and they alter dynamically with pH (Fig. 6 top (a) and (b)) and oxidation state as well as the metal centres’ responsiveness to ligand replacement and redox catalysis 136 (fig below).…”
Section: Copper I and Copper Ii Speciationmentioning
confidence: 99%
“…Copper( ii ) with and without Aβ may both be reduced to copper( i ) in the cellular environment that contains reducing agents (such as ascorbate and glutathione), as illustrated in copper( i )-Aβ may interact with O 2 to create ROS, such as O 2− , H 2 O 2 , and OH, which can oxidatively modify Aβ and alter its aggregation. 141–143 The copper binding sites and binding modes of monomeric Aβ peptides are flexible, and they alter dynamically with pH (Fig. 6 top (a) and (b)) and oxidation state as well as the metal centres’ responsiveness to ligand replacement and redox catalysis 136 (fig below).…”
Section: Copper I and Copper Ii Speciationmentioning
confidence: 99%
“…The potential of PDA-AMSNs to mitigate the effects of ROS was also assessed through a coumarin-3-carboxylic acid (CCA) assay. 37 CCA assay is a fluorescent detection method to detect • OH (hydroxyl radical) in aqueous solution. In the present analysis, the reducing agent ascorbate facilitates the conversion of Cu 2+ to Cu + .…”
Section: ■ Results and Discussionmentioning
confidence: 99%
“…To evaluate the redox silencing activity of our nanoparticles, a CCA assay was performed according to our previously reported protocol. 37 Briefly, it includes incubation of nonfluorescent compound coumarin-3-carboxylic acid (CCA, 150 μM), Cu 2+ (10 μM), and PDA-AMSN or ascorbic acid (10 μM) separately in PBS (0.1 mM, pH = 7.4) at 37 °C. Further, the fluorescent excitation and emission intensity were measured (λ ex = 385 nm, λ em = 452 nm) in the thermo VarioLux scan microplate reader.…”
Section: ■ Materials and Methodsmentioning
confidence: 99%
“…If any molecule is capable of capturing copper from the Aβ-Cu 2+ complex, it will also prevent ROS production. Therefore, to check the effect of SB on ROS generation, we have performed a DCFDA assay. ,, DCFDA measures the different ROS such as hydroxyl and peroxyl groups within the cell. The cellular esterase deacetylated the nonfluorescent DCFDA into a nonfluorescent compound, which was further oxidized by the ROS to the highly fluorescent DCF in the cell.…”
Section: Resultsmentioning
confidence: 99%